NCT02300350View on ClinicalTrials.gov

DDI Study With Multiple-dose LX4211 and Single Dose Digoxin

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Healthy
Interventions
DRUG

Treatment A digoxin

0.5 mg digoxin administered on Day 1 and Day 20

DRUG

Treatment B LX4211

400 mg LX4211 administered daily on Day 14 through Day 25

DRUG

Treatment C Digoxin + 400 mg LX4211 administered concomitantly

0.5 mg Digoxin + 400 mg LX4211 administered concomitantly on Day 20

Trial Locations (1)

75247

Lexicon Investigational Site, Dallas

Sponsors
All Listed Sponsors
lead

Lexicon Pharmaceuticals

INDUSTRY